Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
Recruiting now NCT02744365
Run by CHU de Quebec-Universite Laval · for 18 and older · Women · accepts healthy volunteers
What this study is about
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.
Who can join (things the study team will check)
✅ You may be able to join if…
- (specific to each study)
🚫 You may not be able to join if…
- pregnant women <18 years old at recruitment
- negative fetal heart at recruitment
- women not able to provide an informed consent to the study
Where this trial is running
- CHU de Quebec, Québec, Canada
Who to contact
Emmanuel Bujold, MD, MSc · 418-525-4444 · emmanuel.bujold@crchudequebec.ulaval.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT02744365.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.